1-4 of 4
Emmanuel Raffoux
Close
Sort by
Journal Articles

Blinatumomab consolidation for adult B-cell acute lymphoblastic leukemia in first and second complete remission

Clinical Trials & Observations
Irene Urbino, Etienne Lengliné, Florence Rabian, Marco Cerrano, Rathana Kim, Florian Chevillon, Dario Ferrero, Marie Sébert, Nathalie Dhédin, Raphaël Itzykson, Lionel Adès, Emmanuel Raffoux, Hervé Dombret, Ernesta Audisio, Emmanuelle Clappier, Nicolas Boissel
Journal: Blood Advances
Blood Adv (2024) 8 (10): 2405–2409.
https://doi.org/10.1182/bloodadvances.2023012139
Published: 2024
Includes: Supplemental data
Journal Articles

Early detection of WT1 measurable residual disease identifies high-risk patients, independent of transplantation in AML

Clinical Trials & Observations
Juliette Lambert, Jerome Lambert, Xavier Thomas, Alice Marceau-Renaut, Jean-Baptiste Micol, Aline Renneville, Emmanuelle Clappier, Sandrine Hayette, Christian Récher, Emmanuel Raffoux, Arnaud Pigneux, Celine Berthon, Christine Terré, Karine Celli-Lebras, Sylvie Castaigne, Nicolas Boissel, Philippe Rousselot, Claude Preudhomme, Hervé Dombret, Nicolas Duployez
Journal: Blood Advances
Blood Adv (2021) 5 (23): 5258–5268.
https://doi.org/10.1182/bloodadvances.2021004322
Published: 2021
Includes: Supplemental data
Journal Articles

Real-life experience with CPX-351 and impact on the outcome of high-risk AML patients: a multicentric French cohort

Clinical Trials & Observations
Edmond Chiche, Ramy Rahmé, Sarah Bertoli, Pierre-Yves Dumas, Jean-Baptiste Micol, Yosr Hicheri, Florence Pasquier, Pierre Peterlin, Patrice Chevallier, Xavier Thomas, Michael Loschi, Alexis Genthon, Ollivier Legrand, Mohamad Mohty, Emmanuel Raffoux, Patrick Auberger, Alexis Caulier, Magalie Joris, Caroline Bonmati, Gabrielle Roth-Guepin, Caroline Lejeune, Arnaud Pigneux, Norbert Vey, Christian Recher, Lionel Ades, Thomas Cluzeau
Journal: Blood Advances
Blood Adv (2021) 5 (1): 176–184.
https://doi.org/10.1182/bloodadvances.2020003159
Published: 2021
Includes: Supplemental data
Journal Articles

Added prognostic value of secondary AML-like gene mutations in ELN intermediate-risk older AML: ALFA-1200 study results

Clinical Trials & Observations
Claude Gardin, Cécile Pautas, Elise Fournier, Raphaël Itzykson, Emilie Lemasle, Jean-Henri Bourhis, Lionel Adès, Jean-Pierre Marolleau, Jean-Valère Malfuson, Lauris Gastaud, Emmanuel Raffoux, Juliette Lambert, Thorsten Braun, Xavier Thomas, Sylvain Chantepie, Thomas Cluzeau, Stéphane de Botton, Céline Berthon, Nicolas Boissel, Nicolas Duployez, Christine Terré, Régis Peffault de Latour, Mauricette Michallet, Karine Celli-Lebras, Claude Preudhomme, Hervé Dombret
Journal: Blood Advances
Blood Adv (2020) 4 (9): 1942–1949.
https://doi.org/10.1182/bloodadvances.2019001349
Published: 2020
Includes: Supplemental data